InterWest Partners Advisory Committee

The InterWest Partners Advisory Committee is a highly experienced team of business professionals, which is an invaluable resource for both InterWest and our portfolio companies. They assist in the strategic guidance of our firm, and contribute directly to portfolio companies where their experience and judgment are most applicable.

DR. JEAN-LOU CHAMEAU

President, California Institute of Technology

LEROY HOOD, M.D., Ph.D.

President and Co-Founder, Institute for Systems Biology, pioneering systems approaches to biology and medicine

FRANK J. MARSHALL

Consultant and investor in early-stage IT companies; former Vice President and General Manager, Cisco Systems

MARK McCLELLAN, M.D., Ph.D.

Former Commissioner, U.S. Food and Drug Administration; former Administrator, Centers for Medicare & Medicaid Services; current Director of the Engleberg Center for Health Reform, Senior Fellow in Economic Studies and Leonard D. Schaeffer Director's Chair in Health Policy Studies at the Brookings Institution

PROFESSOR JOHN G. McDONALD

The Stanford Investors Professor in the Graduate School of Business at Stanford University

InterWest Life Sciences Advisory Committee

The Life Sciences Advisory Committee consists of distinguished scientists and physicians from across the country who join InterWest in our commitment to building a world-class health care investment practice.

John Brauman, Ph.D.

Professor of Chemistry
Stanford University

Leroy Hood, M.D., Ph.D.

President and Co-Founder
Institute for Systems Biology

Arnold Levine, Ph.D.

Visiting Professor, Molecular Biology,
Institute for Advanced Study

Larry Smarr, Ph.D.

Director
California Institute for Telecommunications & Information Technology

Paul G. Yock, M.D.

Director, Center for Research & Cardiovascular Interventions
Stanford University School of Medicine